Analytical Data
-
Gene name
TREM-2
- Application
-
Alternative Names
Triggering receptor expressed on myeloid cells 2; TREM-2; Triggering receptor expressed on monocytes 2; TREM2
-
Species
Human
-
Source
HEK293
-
Tag
C-hFc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NZC2-1
-
Expression Region
H19-D131
-
Molecular Weight
46-55 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TREM-2, or Triggering Receptor Expressed on Myeloid Cells 2, is a receptor primarily found on myeloid cells such as microglia and macrophages, playing a crucial role in immune response and neuroinflammation. Recent studies have highlighted its importance in neurodegenerative diseases, particularly Alzheimer's disease, where TREM-2 is implicated in modulating microglial activation and response to amyloid-beta plaques. The receptor enhances the clearance of apoptotic cells and promotes tissue repair, indicating its potential as a therapeutic target. However, the mechanisms underlying TREM-2 signaling remain partially understood. Recombinant TREM-2 proteins are instrumental in elucidating these pathways, allowing researchers to investigate its interactions, ligand-binding dynamics, and downstream effects on cellular responses. Furthermore, there is growing interest in the potential of TREM-2 as a biomarker for neurodegeneration, making recombinant proteins vital for developing diagnostic and therapeutic strategies. Understanding TREM-2 functions and modulation through recombinant protein studies could pave the way for innovative treatments in diseases characterized by chronic inflammation and neuronal damage.
